About Orthofix
Orthofix is a company based in Lewisville (United States) founded in 1980. The company has 1,620 employees. Orthofix has completed 3 acquisitions, including Blackstone Orthopedics & Sports Medicine, Breg and Spinal Kinetics. Orthofix offers products and services including Spine Solutions, Orthopedic Solutions, and Biologics. Orthofix operates in a competitive market with competitors including Stryker, Tenaya Therapeutics, NuVasive, Athira Pharma and Ensoma, among others.
- Annual Revenue$822.31 M (USD)2.85as on Dec 31, 2025
- Net Profit-$92.19 M (USD)26.83as on Dec 31, 2025
- EBITDA$8.85 M (USD)0as on Dec 31, 2025
- Employee Count1,620
- Investments & Acquisitions
Products & Services of Orthofix
Orthofix offers a comprehensive portfolio of products and services, including Spine Solutions, Orthopedic Solutions, and Biologics.
Devices for spinal reconstruction and fusion procedures
Solutions for fracture healing and limb reconstruction
Therapies for bone growth and spinal fusion support
Apps and channels of Orthofix
its YouTube channel Orthofix Orthopedics has 2.45K subscribers and 30 videos.
Videos from Orthofix
The most watched videos on Orthofix's YouTube channel, Orthofix Orthopedics (2.45K subscribers). Click a video to play it here.
More on Orthofix Orthopedics.
People of Orthofix
179 people are tracked at Orthofix (57 in leadership, 122 in team); the tracked headcount is 1,620.
| Name | Role | Group |
|---|---|---|
Mike Hall | Vice President Of Marketing & Medical Education | Leadership |
Leesa Gunter | Vice President, Commercial Operations | Leadership |
Katie Shelgren | Senior Director, Human Resources Business Partners | Leadership |
Michelle Young | Strategic Account Director | Leadership |
Jasmine Roufchaie | Marketing Director | Leadership |
Chris Essman | Senior Manager, HR Business Partner | Leadership |
Jill Mason | Chief Ethics and Compliance Officer | Leadership |
Bruno Geron | Director Of Quality Operations | Leadership |
Vicki Troy | Director Of Patient Care, Appeals, And Training | Leadership |
Elizabeth G. | VP Of Cybersecurity And PMO | Leadership |
Albert Cornejo | Senior Vice President, Biologics | Leadership |
Lucas Vitale | Chief People And Business Operations Officer | Leadership |
Corey Gladieux | Director, Technical Engineering | Leadership |
Negin Behrouzi | Planning Director | Leadership |
Shideh Baker | Vice President, Commercial Strategy | Leadership |
Jay Erturan | Director - Global Lead Clinical & Medical Affairs | Leadership |
Jennifer Wynne | Senior Manager, Human Resources Business Partner | Leadership |
Jeannie Miller | Global Director, Orthofix Learning | Leadership |
Keith Crum | Director, U.s. Facility Management & Safety | Leadership |
Robert Wagner | Senior Director, Infrastructure Operations | Leadership |
159 more people are available in the full profile.
Complete people profiles for Orthofix
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Orthofix
Orthofix is a publicly listed company on the NASDAQ with ticker symbol OFIX in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date27 Jun 1996
- Listed onNASDAQ: OFIX
- Listed entityOrthofix Medical Inc.
- Exchange sectorHealth technology
- ISINUS68752M1080
- Share price$9.17 (+1.89% on the day) · 2026-10-09
- Market capitalisation$373.5M
- EPS (diluted, trailing year)$-1.53
- Volume (last session)314,178
Financials of Orthofix
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $822.3M | -$92.2M | $8.8M |
| 2024 | $799.5M | -$126.0M | -$17.7M |
| 2023 | $746.6M | -$151.4M | -$88.7M |
| 2022 | $460.7M | -$19.8M | $151,000 |
| 2021 | $464.5M | -$38.4M | $31.0M |
Detailed financial statements for Orthofix
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Orthofix
Orthofix has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Blackstone Orthopedics & Sports Medicine, Breg and Spinal Kinetics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Artificial spine discs are developed for degenerative spinal diseases. | spinalkinetics.com | Sunnyvale, United States | 2003 | Mar 2018 | •••• | |
Fusion, non-fusion, and biologic products for spinal disorders are developed. | blackstoneorthopedics.com | Pawtucket, United States | 2013 | Aug 2006 | $333M | |
Orthopedic braces and supports for joint rehabilitation are supplied. | breg.com | San Diego, United States | 1989 | Nov 2003 | •••• |
Complete acquisition details for Orthofix
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Orthofix
5 dated milestones of Orthofix across 38 years, from founding to its latest funding, stage changes and deals.
- Founded Orthofix is founded.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Breg.
- Acquisition Acquires Blackstone Orthopedics & Sports Medicine.
- Acquisition Acquires Spinal Kinetics.
Competitors of Orthofix
Orthofix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Stryker, Tenaya Therapeutics, NuVasive, Athira Pharma and Ensoma, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| stryker.com | 1941 | Kalamazoo, United States | – | 25,035 | 3D-printed orthopedic products are manufactured for medical applications. | |
| tenayatherapeutics.com | 2016 | San Francisco, United States | $142M | 140 | Regenerative and gene therapeutics for heart failure are developed. | |
| nuvasive.com | 1997 | San Diego, United States | $54.1M | 2,450 | Smart surgical devices for spinal surgery are developed. | |
| athira.com | 2011 | Seattle, United States | $121.04M | 62 | Neurodegenerative disease therapeutics, including for Alzheimer’s and Parkinson’s, are developed. | |
| ensoma.com | 2019 | Boston, United States | $205M | 52 | Provider of in vivo stem cell modification technologies and vector-based drug delivery tool | |
| orcabio.com | 2016 | Menlo Park, United States | $192M | 66 | Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders | |
| avitamedical.com | 1992 | Cambridge, United Kingdom | – | 108 | Products for regenerative and respiratory medicine are developed and distributed. | |
| tunetx.com | 2009 | Seattle, United States | $222.41M | – | Cell and gene therapies are developed via an epigenomic platform. | |
| intech-medical.com | 2000 | – | – | 271 | Surgical instruments for orthopaedics are developed and manufactured. | |
| carlsmed.com | 2018 | San Diego, United States | $109.63M | 59 | Developer of devices for spine surgery |
Detailed competitors of Orthofix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Orthofix
The website of Orthofix (orthofix.com) receives about 48.4K visits a month.
- Monthly visits48.4K
▲ 11.9% vs previous month
Websites whose visitors overlap most with Orthofix. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
wmt.com | wmt.com | 100% | – | – | – |
synthes.com | synthes.com | 99% | – | #12,897,470 | – |
alphatecspine.com | alphatecspine.com | 99% | – | #3,976,987 | – |
| biomet.com | 92% | 1.7K | #10,154,264 | View details | |
| smith-nephew.com | 89% | 296.7K | #152,630 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Orthofix
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Orthofix
Complete news archive for Orthofix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Orthofix
10 companies that operate in the same segment as Orthofix (Cell Therapy), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
CAR-T and TIL immunotherapies for solid tumors are developed. | 2018 | San Francisco, California, United States | USD 493 M | USD 36 K | 300 | |
T-cell-based immunotherapies for cancer treatment are developed. | 2000 | Tubingen, Baden-wurttemberg, Germany | USD 236.4 M | USD 54.47 M | 423 | |
Engineered T-cell immunotherapies are developed for cancer and auto-immune diseases. | 2015 | London, England, United Kingdom | USD 181.37 M | USD 75.56 M | 647 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M | – | – | |
Genetically engineered cell therapies are developed for multiple disorders. | 2018 | Seattle, Washington, United States | USD 821 M | – | 194 | |
Provider of bio-artificial pancreas for Type 1 Diabetes treatment | 2015 | Cambridge, Massachusetts, United States | USD 158 M | – | 58 | |
T-cell and antibody-based therapeutics are developed via single-cell sequencing platforms. | 2011 | San Francisco, California, United States | USD 36.13 M | – | 36 | |
Developer of immune cell therapies | 2019 | San Francisco, California, United States | USD 631.16 M | – | 178 | |
Cue Biopharma is focused on developing immunotherapy solutions. | 2015 | Cambridge, Massachusetts, United States | USD 10 M | USD 27.47 M | 41 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Orthofix
Orthofix was founded in 1980.
Orthofix is headquartered in Lewisville, United States. It is registered at Lewisville, Texas, United States.
Orthofix has 1,620 employees.
Annual revenue of Orthofix is $822.31M as on Dec 31, 2025.
The company was founded in 1980 and is based in Lewisville, United States. Operations are conducted in the medical device sector, with a focus on orthopedics and spine care. Reconstructive and regenerative solutions for bone-related conditions are developed and provided. Minimally invasive extremity solutions are offered to support patient recovery in orthopedic and spine applications.
Orthofix's top competitors include Stryker, NuVasive and Tenaya Therapeutics.
Orthofix offers Spine Solutions, Orthopedic Solutions, and Biologics.
Yes, Orthofix is publicly traded on NASDAQ under the ticker symbol OFIX.
Orthofix has made 3 acquisitions, including Blackstone Orthopedics & Sports Medicine, Breg, and Spinal Kinetics.
Orthofix operates through Orthofix Medical Inc..